51吃瓜网

Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

v3.22.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock
Additional Paid-In Capital
Treasury Stock
Accumulated Deficit
Beginning balance at Apr. 30, 2020 $ 41,747,957 $ 21,771 $ 89,505,216 $ (70,000) $ (47,709,030)
Beginning balance (in shares) at Apr. 30, 2020 21,770,520
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation 3,019,828 3,019,828
Common stock issued for stock options exercised for cash 2,578,700 $ 1,365 4,394,749 (1,817,414)
Common stock issued for stock options exercised for cash (in shares) 1,364,721
Common stock issued for cashless stock options exercised 0 $ 22 (22)
Common stock issued for cashless stock options exercised (in shares) 22,339
Common stock issued for conversion of Convertible Notes 10,000,000 $ 1,399 9,998,601
Common stock issued for conversion of Convertible Notes (in shares) 1,398,602
Common stock issued for vested restricted stock units 0 $ 206 (206)
Common stock issued for vested restricted stock units (in shares) 206,109
Common stock issued for warrants exercised for cash 1,081,792 $ 192 1,081,600
Common stock issued for warrants exercised for cash (in shares) 192,049
Common stock issued for services 19,900 $ 2 19,898
Common stock issued for services (in shares) 2,000
Modification charge for warrants exercised 25,966 25,966
Amortization of warrant based cost 27,375 27,375
Cancellation of Treasury Stock 0 $ (17) (69,983) 70,000
Cancellation of Treasury Stock (in shares) (16,667)
Net loss (8,128,987) (8,128,987)
Ending balance at Jan. 31, 2021 50,372,531 $ 24,940 108,003,022 (1,817,414) (55,838,017)
Ending balance (in shares) at Jan. 31, 2021 24,939,673
Beginning balance at Oct. 31, 2020 52,094,217 $ 24,417 105,092,551 0 (53,022,751)
Beginning balance (in shares) at Oct. 31, 2020 24,416,539
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation 701,170 701,170
Common stock issued for stock options exercised for cash 363,385 $ 447 2,180,352 (1,817,414)
Common stock issued for stock options exercised for cash (in shares) 447,134
Common stock issued for vested restricted stock units 0 $ 74 (74)
Common stock issued for vested restricted stock units (in shares) 74,000
Common stock issued for services 19,900 $ 2 19,898
Common stock issued for services (in shares) 2,000
Amortization of warrant based cost 9,125 9,125
Net loss (2,815,266) (2,815,266)
Ending balance at Jan. 31, 2021 50,372,531 $ 24,940 108,003,022 (1,817,414) (55,838,017)
Ending balance (in shares) at Jan. 31, 2021 24,939,673
Beginning balance at Apr. 30, 2021 49,090,474 $ 25,067 109,040,824 (1,817,414) (58,158,003)
Beginning balance (in shares) at Apr. 30, 2021 25,066,297
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation 1,965,567 1,965,567
Common stock issued for stock options exercised for cash 191,034 $ 58 190,976
Common stock issued for stock options exercised for cash (in shares) 58,419
Common stock issued for cashless stock options exercised 0 $ 30 (30)
Common stock issued for cashless stock options exercised (in shares) 30,156
Common stock issued for vested restricted stock units 0 $ 74 (74)
Common stock issued for vested restricted stock units (in shares) 73,708
Amortization of warrant based cost 43,708 43,708
Warrants issued for deferred financing costs related to Credit Facility 137,500 137,500
Net loss (7,457,143) (7,457,143)
Ending balance at Jan. 31, 2022 43,971,140 $ 25,229 111,378,471 (1,817,414) (65,615,146)
Ending balance (in shares) at Jan. 31, 2022 25,228,580
Beginning balance at Oct. 31, 2021 46,853,315 $ 25,149 110,526,729 (1,817,414) (61,881,149)
Beginning balance (in shares) at Oct. 31, 2021 25,148,194
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation 700,697 700,697
Common stock issued for stock options exercised for cash 135,000 $ 41 134,959
Common stock issued for stock options exercised for cash (in shares) 41,667
Common stock issued for vested restricted stock units 0 $ 39 (39)
Common stock issued for vested restricted stock units (in shares) 38,719
Amortization of warrant based cost 16,125 16,125
Net loss (3,733,997) (3,733,997)
Ending balance at Jan. 31, 2022 $ 43,971,140 $ 25,229 $ 111,378,471 $ (1,817,414) $ (65,615,146)
Ending balance (in shares) at Jan. 31, 2022 25,228,580